Latest 10-K annual reports
OTC.Pink
Papaya Growth Opportunity Corp. I's 10-K filing reveals a company struggling to find a business combination target as its deadline approaches, shares delist, and redemptions deplete its trust account.
NASDAQ
Nexalin Technology files an amendment to its 2024 annual report to include the Insider Trading Policy and Compensation Recoupment Policy exhibits.
OQB
CareView Communications files an amendment to its annual report on Form 10-K to revise information regarding the security ownership of certain beneficial owners and management.
OQB
Cyber Enviro-Tech, Inc. reports a net loss of $6.37 million for 2024, driven by increased asset impairment and operating expenses, as the company focuses on water and oil remediation and plans to spin off its Alvey oil field.
NASDAQ
ISPC
Ispecimen INCiSpecimen Inc.'s annual report reveals a net loss of $12.5 million for 2024 and raises substantial doubt about the company's ability to continue as a going concern.
OTC.Pink
10-K: Healthier Choices Management Corp. Reports FY24 Results, Navigates Spin-Off and Patent Litigation
Healthier Choices Management Corp. (HCMC) reports its fiscal year 2024 results, highlighting the spin-off of its grocery segment, ongoing patent litigation, and efforts to manage its intellectual property portfolio.
NUKK
Nukkleus INCNukkleus Inc. files an amendment to its annual report to include information on its policy for recovering erroneously awarded compensation, while also detailing its business strategy, recent developments, and financial performance.
AMEX
Contango Ore, Inc. files an amendment to its annual report to include its policy regarding the mandatory recovery of compensation from executive officers in the event of a financial restatement.
OID
TWOH
Two Hands CORPTwo Hands Corporation reports a net loss for fiscal year 2024 and announces a strategic shift away from wholesale food distribution to focus on artisan denim and premium cotton yarns.
OQB
SKVI
Skinvisible, INCSkinvisible, Inc. files its 10-K for the year ended December 31, 2024, highlighting ongoing efforts to license its Invisicare technology and advancements in clinical trials by its licensee, Quoin Pharmaceuticals.
OQB
10-K: Emmaus Life Sciences Reports FY2024 Results, Cites Revenue Decline and Going Concern Uncertainty
Emmaus Life Sciences' 10-K filing reveals a significant revenue drop in 2024 and raises substantial doubt about the company's ability to continue as a going concern.
OTC.Pink
REMSleep Holdings, Inc. reports a net loss for 2024 but recognizes revenue from ResPlus CPAP system sales and continues development of its DeltaWave product.
NASDAQ
Stran & Company's 2024 10-K filing reveals an 8.8% increase in sales offset by a net loss due to rising operating expenses, acquisition costs, and identified material weaknesses in internal controls.
AlphaVest Acquisition Corp's latest 10-K filing reveals substantial doubt about its ability to continue as a going concern due to its dependence on completing a business combination and a looming liquidation deadline.
NASDAQ
Merit Medical Systems has filed an amendment to its annual report to correct the five-year cumulative total return information for NASDAQ Stocks within its original filing.
NYSE
SKIL
Skillsoft CORPSkillsoft Corp. outlines the terms and conditions for performance stock unit grants under its 2020 Omnibus Incentive Plan.
NASDAQ
OTRK
Ontrak, INCOntrak, Inc.'s 2024 10-K filing reveals a net loss of $25.49 million and raises substantial doubt about the company's ability to continue as a going concern due to recurring losses and the need for additional capital.
NASDAQ
GT Biopharma files an amendment to its 2024 Form 10-K to include the company's Compensation Recovery Policy as an exhibit.
NASDAQ
TOMI Environmental Solutions reports a 5% increase in annual revenue for 2024, but acknowledges substantial doubt about its ability to continue as a going concern due to recurring losses and limited cash reserves.
NASDAQ
Currenc Group Inc. reports its financial results for the year ended December 31, 2024, highlighting key financial metrics and strategic developments after its business combination.
OQB
DPLS
Darkpulse, INCDarkPulse Inc.'s 2024 10-K filing reveals a net loss, decreased revenues, and ongoing efforts to secure additional financing amid substantial doubt about its ability to continue as a going concern.
OQB
Free Flow USA Inc.'s 2024 annual report reveals a revenue increase and a shift to net income, driven by asset sales and trading activities.
OID
Elvictor Group, Inc. announces a net income of $199,780 for the year ended December 31, 2024, a significant turnaround from the previous year's net loss, driven by increased revenues and reduced operating expenses.
OTC.Pink
TCRI
Techcom, INCTechCom, Inc., a non-operating holding company, filed its Form 10-K for the fiscal year ended December 31, 2024, reporting no revenue and expressing substantial doubt about its ability to continue as a going concern.
NASDAQ
Virco Mfg. Corporation reports a slight decrease in net sales for fiscal year 2025 amid stable commodity costs and anticipates potential impacts from new U.S. trade policies.
NASDAQ
GOAI
Eva Live INCEva Live Inc.'s Form 10-K reveals a year of increased revenue but continued net losses, a reverse capitalization adjustment, and substantial doubt about its ability to continue as a going concern.
NASDAQ
Socket Mobile files an amendment to its 2024 annual report to include its clawback policy in compliance with Nasdaq listing rules.
NASDAQ
10-K: Innventure's 10-K Filing Reveals Shift to Disruptive Conglomerate Model, Focus on Long-Term Value
Innventure's 2024 10-K highlights a strategic shift towards a 'Disruptive Conglomerate Model,' emphasizing long-term value creation through majority ownership of its operating companies.
OQB
10-K: American Picture House Corporation Files 10-K, Outlines Strategy for Film and TV Content Development
American Picture House Corporation (APHP) files its annual report on Form 10-K, detailing its focus on developing, financing, and producing mid-budget feature films and limited series, while navigating financial challenges and competitive industry landscape.
OTC.Pink
Stark Focus Group Inc.'s 10-K filing reveals a net loss of $47,225 for the year ended December 31, 2024, and raises substantial doubt about the company's ability to continue as a going concern.